搜索临床试验以:Drug: Paclitaxel; trastuzumab; doxorrubicin; cyclophosphamide
总计9042个结果
-
Instituto do Cancer do Estado de São PauloFundação Faculdade de Medicina终止Locally Advanced HER2-positive Breast Cancer巴西
-
NSABP Foundation IncNational Cancer Institute (NCI)完全的
-
Lawson Health Research InstituteThe Ottawa Hospital完全的
-
NSABP Foundation IncGlaxoSmithKline未知
-
Instituto Nacional de Cancerologia, Columbia未知
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Dana-Farber Cancer Institute完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Breast Cancer Research Foundation完全的
-
University of WashingtonNational Cancer Institute (NCI)完全的HER2阳性乳腺癌 | IV 期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性乳腺癌美国
-
National Cancer Institute (NCI)NRG Oncology主动,不招人复发性乳腺癌 | HER2/Neu阳性 | 孕激素受体阳性 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | IIIA 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7美国, 加拿大, 波多黎各, 爱尔兰
-
Novartis Pharmaceuticals完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Fondazione MichelangeloHoffmann-La Roche主动,不招人
-
Peking Union Medical CollegeCSPC Ouyi Pharmaceutical Co., Ltd.未知
-
University of Kansas Medical CenterCelgene Corporation完全的
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); United States Department of Defense完全的
-
Instituto do Cancer do Estado de São PauloFundação Faculdade de Medicina终止Locally Advanced HER2-negative Breast Cancer巴西
-
Sanofi完全的乳腺肿瘤西班牙, 意大利, 澳大利亚, 捷克共和国, 德国, 匈牙利, 爱尔兰, 以色列, 新西兰, 葡萄牙, 斯洛文尼亚, 斯洛伐克, 奥地利, 瑞典, 英国, 比利时, 巴西, 智利, 丹麦, 南非, 瑞士
-
Tianjin Medical University Cancer Institute and...Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University尚未招聘HER2+ Early or Locally Advanced Breast Cancer
-
QuantumLeap Healthcare CollaborativeByondis B.V.撤销卵巢癌 | 转移癌 | 转移性乳腺癌 | 膀胱癌 | 三阴性乳腺癌 | HER2阳性乳腺癌 | 胃食管腺癌 | 卵巢癌 | HER2阳性胃癌 | 转移性胃肠道类癌 | HER2阳性转移性乳腺癌 | 孕激素受体阳性乳腺癌 | 胃食管癌 | 雌激素受体阳性肿瘤 | 激素受体阳性乳腺癌 | 转移性 | HER-2 蛋白过表达 | 激素受体阴性乳腺癌 | HER2低 | SYD-985 | SYD985 | Vic-trastuzumab Duocarmazine | HER2低位乳腺癌 | 子宫内膜肿瘤 | HER2突变相关肿瘤 | HER2 低 HR 阳性 | 人力资源积极美国
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen...主动,不招人
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人
-
AstraZenecaDaiichi Sankyo主动,不招人乳腺癌 | 乳腺肿瘤 | HER2阳性早期乳腺癌美国, 意大利, 西班牙, 波兰, 台湾, 泰国, 加拿大, 德国, 大韩民国, 巴西, 印度, 日本, 秘鲁, 菲律宾, 中国, 沙特阿拉伯, 俄罗斯联邦, 保加利亚
-
German Breast GroupAGO Study Group完全的
-
Herlev HospitalOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark完全的
-
Hospital Universitario Madrid Sanchinarro未知
-
Commissie Voor Klinisch Toegepast Onderzoek未知
-
Cancer Institute and Hospital, Chinese Academy...CSPC Ouyi Pharmaceutical Co., Ltd.尚未招聘